FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review Authorization Includes Restrictions to Mitigate Youth Risk

https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-four-menthol-flavored-e-cigarette-products-after-extensive-scientific?utm_medium=email&utm_source=govdelivery FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review Authorization Includes Restrictions to Mitigate Youth Risk Following an extensive scientific review, the U.S. Food and Drug Administration authorized the marketing of four e-cigarette products in the United States through the premarket tobacco product application (PMTA) pathway. The FDA issued marketing granted orders to NJOY LLC for four menthol-flavored e-cigarette products – NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY EXTRA Menthol 6%. The two authorized ACE products are sealed, pre-filled, non-refillable pods that are used with the previously authorized ACE device, and the two authorized DAILY products are disposable e-cigarettes with a prefilled, non-refillable e-liquid reservoir.